Status:

NOT_YET_RECRUITING

Implementation of the 3-steps Assess-Advise-Refer Exercise (FitARise) Protocol as a Standard Practice in Cancer Care

Lead Sponsor:

The University of Hong Kong

Conditions:

Exercise

Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study proposes to evaluate the process and outcome of an implementation program designed to implement the American College of Sports Medicine (ACMS)-recommended exercise assessment, advice, and r...

Detailed Description

This study aims to test whether using implementing strategies (audit, feedback, facilitation, and adaptable workflow) to adopt the systematic FitARise protocol increases the proportion of eligible pat...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Cancer patients):
  • All cancer patients with BMI score\>=23;
  • Have completed cancer treatment within the past five years;
  • At least 18 years old;
  • Are literate in Chinese or English;
  • Are eligible to attend the intervention program.
  • Exclusion Criteria (Cancer patients):
  • Patients who have completed cancer treatments for more than five years;
  • Non-Cantonese, non-Mandarin, non-English speakers.
  • Inclusion Criteria (Clinical staff):
  • \- All clinical, medical or surgical oncologists at the study units during the study period.
  • Exclusion Criteria (Clinical staff):
  • \- No exclusion criterial for staff.

Exclusion

    Key Trial Info

    Start Date :

    December 1 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 2 2028

    Estimated Enrollment :

    1800 Patients enrolled

    Trial Details

    Trial ID

    NCT07210905

    Start Date

    December 1 2025

    End Date

    February 2 2028

    Last Update

    December 10 2025

    Active Locations (8)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (8 locations)

    1

    KWH Department of Surgery

    Hong Kong, Hong Kong

    2

    PMH Department of Oncology

    Hong Kong, Hong Kong

    3

    PYEH Department of Clinical Oncology

    Hong Kong, Hong Kong

    4

    QMH Department of Clinical Oncology

    Hong Kong, Hong Kong